137 related articles for article (PubMed ID: 30785183)
1. Morelloflavone as a novel inhibitor of mitotic kinesin Eg5.
Ogunwa TH; Taii K; Sadakane K; Kawata Y; Maruta S; Miyanishi T
J Biochem; 2019 Aug; 166(2):129-137. PubMed ID: 30785183
[TBL] [Abstract][Full Text] [Related]
2. Kolaflavanone, a biflavonoid derived from medicinal plant Garcinia, is an inhibitor of mitotic kinesin Eg5.
Alrazi IMD; Ogunwa TH; Kolawole AO; Elekofehinti OO; Omotuyi OI; Miyanishi T; Maruta S
J Biochem; 2021 Dec; 170(5):611-622. PubMed ID: 34264310
[TBL] [Abstract][Full Text] [Related]
3. Insights into the Molecular Mechanisms of Eg5 Inhibition by (+)-Morelloflavone.
Ogunwa TH; Laudadio E; Galeazzi R; Miyanishi T
Pharmaceuticals (Basel); 2019 Apr; 12(2):. PubMed ID: 30995725
[TBL] [Abstract][Full Text] [Related]
4. Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5.
Brier S; Lemaire D; Debonis S; Forest E; Kozielski F
Biochemistry; 2004 Oct; 43(41):13072-82. PubMed ID: 15476401
[TBL] [Abstract][Full Text] [Related]
5. Photocontrol of the mitotic kinesin Eg5 using a novel S-trityl-L-cysteine analogue as a photochromic inhibitor.
Ishikawa K; Tohyama K; Mitsuhashi S; Maruta S
J Biochem; 2014 Apr; 155(4):257-63. PubMed ID: 24451491
[TBL] [Abstract][Full Text] [Related]
6. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5.
Maliga Z; Kapoor TM; Mitchison TJ
Chem Biol; 2002 Sep; 9(9):989-96. PubMed ID: 12323373
[TBL] [Abstract][Full Text] [Related]
7. S-trityl-L-cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression.
Skoufias DA; DeBonis S; Saoudi Y; Lebeau L; Crevel I; Cross R; Wade RH; Hackney D; Kozielski F
J Biol Chem; 2006 Jun; 281(26):17559-69. PubMed ID: 16507573
[TBL] [Abstract][Full Text] [Related]
8. Isolation of six isoprenylated biflavonoids from the leaves of Garcinia subelliptica.
Ito T; Yokota R; Watarai T; Mori K; Oyama M; Nagasawa H; Matsuda H; Iinuma M
Chem Pharm Bull (Tokyo); 2013; 61(5):551-8. PubMed ID: 23649198
[TBL] [Abstract][Full Text] [Related]
9. Molecular dissection of the inhibitor binding pocket of mitotic kinesin Eg5 reveals mutants that confer resistance to antimitotic agents.
Brier S; Lemaire D; DeBonis S; Forest E; Kozielski F
J Mol Biol; 2006 Jul; 360(2):360-76. PubMed ID: 16780877
[TBL] [Abstract][Full Text] [Related]
10. In vitro screening for inhibitors of the human mitotic kinesin Eg5 with antimitotic and antitumor activities.
DeBonis S; Skoufias DA; Lebeau L; Lopez R; Robin G; Margolis RL; Wade RH; Kozielski F
Mol Cancer Ther; 2004 Sep; 3(9):1079-90. PubMed ID: 15367702
[TBL] [Abstract][Full Text] [Related]
11. Photocontrol of mitotic kinesin Eg5 facilitated by thiol-reactive photochromic molecules incorporated into the loop L5 functional loop.
Ishikawa K; Tamura Y; Maruta S
J Biochem; 2014 Mar; 155(3):195-206. PubMed ID: 24334276
[TBL] [Abstract][Full Text] [Related]
12. Doing the methylene shuffle--further insights into the inhibition of mitotic kinesin Eg5 with S-trityl L-cysteine.
Abualhasan MN; Good JA; Wittayanarakul K; Anthony NG; Berretta G; Rath O; Kozielski F; Sutcliffe OB; Mackay SP
Eur J Med Chem; 2012 Aug; 54():483-98. PubMed ID: 22749640
[TBL] [Abstract][Full Text] [Related]
13. Morelloflavone from Garcinia dulcis as a novel biflavonoid inhibitor of HMG-CoA reductase.
Tuansulong KA; Hutadilok-Towatana N; Mahabusarakam W; Pinkaew D; Fujise K
Phytother Res; 2011 Mar; 25(3):424-8. PubMed ID: 20734327
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of new allosteric inhibition in Kinesin spindle protein Eg5.
Yokoyama H; Sawada J; Katoh S; Matsuno K; Ogo N; Ishikawa Y; Hashimoto H; Fujii S; Asai A
ACS Chem Biol; 2015 Apr; 10(4):1128-36. PubMed ID: 25622007
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5.
DeBonis S; Simorre JP; Crevel I; Lebeau L; Skoufias DA; Blangy A; Ebel C; Gans P; Cross R; Hackney DD; Wade RH; Kozielski F
Biochemistry; 2003 Jan; 42(2):338-49. PubMed ID: 12525161
[TBL] [Abstract][Full Text] [Related]
16. Photo-control of the mitotic kinesin Eg5 using a novel photochromic inhibitor composed of a spiropyran derivative.
Sadakane K; Takaichi M; Maruta S
J Biochem; 2018 Sep; 164(3):239-246. PubMed ID: 29718428
[TBL] [Abstract][Full Text] [Related]
17. New chemical tools for investigating human mitotic kinesin Eg5.
Klein E; DeBonis S; Thiede B; Skoufias DA; Kozielski F; Lebeau L
Bioorg Med Chem; 2007 Oct; 15(19):6474-88. PubMed ID: 17587586
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship of S-trityl-L-cysteine analogues as inhibitors of the human mitotic kinesin Eg5.
Debonis S; Skoufias DA; Indorato RL; Liger F; Marquet B; Laggner C; Joseph B; Kozielski F
J Med Chem; 2008 Mar; 51(5):1115-25. PubMed ID: 18266314
[TBL] [Abstract][Full Text] [Related]
19. Leishmanicidal, antiproteolytic and antioxidant evaluation of natural biflavonoids isolated from Garcinia brasiliensis and their semisynthetic derivatives.
Gontijo VS; Judice WA; Codonho B; Pereira IO; Assis DM; Januário JP; Caroselli EE; Juliano MA; de Carvalho Dosatti A; Marques MJ; Viegas Junior C; Henrique dos Santos M
Eur J Med Chem; 2012 Dec; 58():613-23. PubMed ID: 23178961
[TBL] [Abstract][Full Text] [Related]
20. STLC-resistant cell lines as tools to classify chemically divergent Eg5 targeting agents according to their mode of action and target specificity.
Indorato RL; DeBonis S; Kozielski F; Garcia-Saez I; Skoufias DA
Biochem Pharmacol; 2013 Nov; 86(10):1441-51. PubMed ID: 24041742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
